Skip to main content

and
  1. No Access

    Article

    Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia

    Introduction: Congenital diaphragmatic hernia (CDH) remains a frustating cause of respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN). Although in...

    B. Thébaud, C. Saizou, C. Farnoux, J. F. Hartman, J. C. Mercier in Intensive Care Medicine (1999)

  2. Article

    Hemodynamics and oxygenation changes induced by the discontinuation of low-dose inhalational nitric oxide in newborn infants

    To assess changes associated with nitric oxide (NO) discontinuation in neonates receiving inhalational NO therapy as a treatment for pulmonary hypertension of the neonate (PPHN).

    M. Françoise, J. B. Gouyon, J. C. Mercier in Intensive Care Medicine (1996)

  3. No Access

    Chapter

    Persistent Pulmonary Hypertension of the Newborn

    Persistent pulmonary hypertension of the newborn (PPHN) is a complex disorder associated with a wide array of cardiopulmonary diseases. PPHN is characterized by marked pulmonary hypertension and altered vasore...

    J. C. Mercier, A. T. Dinh-Xuan, S. H. Abman in Role of Nitric Oxide in Sepsis and ADRS (1995)